Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet GALLI AD 0.74-1.85 GBq radionuclide generator
- Product code:
- W71434001
- Indicated for:
- diagnostic imaging
- Route of administration:
- intravenous
- Substance:
- germanium (68Ge) chloride / gallium (68Ga) chloride (contrast agent)
- ATC
- V09X — Various | Other diagnostic radiopharmaceuticals
Precautions:
Additional monitoring
This medicine is subject to additional monitoring.
Germanium (68Ge) chloride - gallium (68Ga) chloride refers to a radiopharmaceutical generator used in nuclear medicine to produce radioactive gallium solution. This solution is not usually injected directly into the patient; it is used in authorised facilities to radiolabel diagnostic medicines for PET imaging.
Its main role is to prepare imaging agents that may help doctors visualise certain tumours, inflammation or biological processes, depending on the gallium-labelled medicine. Gallium (68Ga) has a short half-life, so its radioactivity falls quickly. The benefit for the patient depends on the final radiopharmaceutical and on the clinical question being investigated.
When needed, the patient receives the prepared radiopharmaceutical by intravenous injection before the PET scan. Nuclear medicine staff check identity, indication, radioactive dose and product quality before administration. Tell the doctor if you are pregnant, think you may be pregnant or are breastfeeding, because radiation exposure must be justified and adjusted to the situation.
Side effects are mainly related to the final labelled medicine rather than to the generator itself. Rarely, injection-site pain, allergic reactions or temporary discomfort may occur. After the scan, you may be advised to drink fluids and urinate often to help clear radioactivity. Follow any local instructions about close contact with pregnant women or small children after imaging.
Its main role is to prepare imaging agents that may help doctors visualise certain tumours, inflammation or biological processes, depending on the gallium-labelled medicine. Gallium (68Ga) has a short half-life, so its radioactivity falls quickly. The benefit for the patient depends on the final radiopharmaceutical and on the clinical question being investigated.
When needed, the patient receives the prepared radiopharmaceutical by intravenous injection before the PET scan. Nuclear medicine staff check identity, indication, radioactive dose and product quality before administration. Tell the doctor if you are pregnant, think you may be pregnant or are breastfeeding, because radiation exposure must be justified and adjusted to the situation.
Side effects are mainly related to the final labelled medicine rather than to the generator itself. Rarely, injection-site pain, allergic reactions or temporary discomfort may occur. After the scan, you may be advised to drink fluids and urinate often to help clear radioactivity. Follow any local instructions about close contact with pregnant women or small children after imaging.
General data about GALLI AD 0.74-1.85 GBq
- Substance:
- germanium (68Ge) chloride / gallium (68Ga) chloride
- Product code:
- W71434001
- Concentration:
- 0.74-1.85GBq
- Pharmaceutical form:
- radionuclide generator
- Product type:
- Generic medicine
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for germanium (68Ge) chloride / gallium (68Ga) chloride
- 0.74-1.85GBq
- 1.85GBq